CEACAM5 and colorectal carcinoma: The Kaplan-Meier survival curves show the OS and DFS rates according to the CEA/CK/CD133 gene expression status in CRC patients with Dukes' stage B and C. In this analysis, the average follow-up time for OS was 36.1±20.7 months and that of DFS was 38.8±16.2 months.